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ABSTRACT
PURPOSE: To investigate the blood vessels’ concentration in TRAM flap’s rat model, in the presence of pentoxifylline. 
METHODS: 32 male, Wistar-EPM rats were divided into two groups. Control group (C): 0.5 ml of saline, intraperitoneally, once a 
day, for seven days before flap elevation; PTX group (P): pentoxifylline (20mg/kg/day), intraperitoneally, for seven days before flap 
elevation. After that, they were submitted to a caudal unipedicle TRAM flap. On the fifth postoperative day, percentages of flap necrosis 
were determined via the “paper template” method and Tram flap’s zone IV skin biopsies were taken for histological analysis. 
RESULTS: the mean percentage of flap necrosis in group C was 58.7 % and in group P, 31.1 (Wilcoxon test; p = 0.003). Mean capillary 
vessels number in zone IV’s skin in C group was 33.4 and in P group was 71.9 (p=0.008). 
CONCLUSIONS: Pentoxifylline was effective reducing the necrosis in the caudal unipedicle TRAM flap in the rat as well as increasing 
the number of capillaries in an ischemic zone (zone IV).
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Introduction
The Transverse Rectus Abdominis Myocutaneous flap 
(TRAM flap) became one of the main techniques for breast 
reconstruction after mastectomy. Despite great advances 
in reconstructive surgery in the last decades, a number of 
difficulties and complications remain. Among them, the most 
worrying is necrosis1-3. 
Both extrinsic and intrinsic factors are involved in the 
genesis of TRAM flap’s necrosis, but the main villain is insufficient 
blood flow, an intrinsic aspect1,3,4. Necrosis in the TRAM flap, for 
the most part in zone IV, the most distant from the pedicle, has 
been of great concern5-7.
Numerous researches were performed in order to find a 
way to increase TRAM flap’s viability. TRAM flap’s rat model 
simulates the procedure and allows studies on flap perfusion and 
viability. Drug induced TRAM flap’s necrosis reduction was 
obtained, mainly by stimulating its microcirculation, but surgeons 
still look for a more efficient drug2,5,6.
 Pentoxifylline, a sub product of methylxantine, 
improves tissue perfusion in peripheral vascular disease. It acts 
in the microcirculation, augmenting erythrocytes’ flexibility 
and reducing blood viscosity, by lowering plasmatic fibrinogen 
levels. It has a thromboprophylatic effect, as well as an influence 
in the reduction of neutrophylic infiltration and in the inhibition 
of production of α-TNF by inflammatory cells6-12.  Experimental 
studies showed that pentoxifylline significantly reduced skin flaps’ 
necrosis in rats, when used before the surgical procedure, but the 
exact mechanisms involved remain unclear. 
This study aimed at investigating blood vessels’ concentration 
in TRAM flap’s rat model, in the presence of pentoxifylline.
Methods
Thirty two Wistar-EPM rats were selected, at random, 
weighted (mean 300 g), kept in individual cages and kept without 
any alimentary restriction until study’s day, when they were 
randomly separated in two groups: 
C Group (n=16) - control: caudally based unipedicle 
TRAM flap and saline (0.5 ml), intraperitoneally, once a day, for 
seven days before  flap elevation;
P Group (n=16) – pentoxifylline: same flap and 
pentoxifylline (20 mg/kg in 0.5 ml), intraperitoneally, once a day, 
for seven days before flap elevation.
After this preoperative period, the rats were anesthetized 
with Tiletamin Chloridrate (25 mg/kg) and Zolazepam Chloridrate 
(25 mg/kg), intraperitoneally and positioned in dorsal decubit on 
a flat surface, immobilized with extended limbs and manually 
depilated in the abdominal areas.  The TRAM flap (3 x 5 cm) was 
then delineated and elevated.
On the fifth postoperative day, the rats were anesthetized 
and the percentages of flaps’ necrosis determined via the “paper 
template method”13. The limit between viable (soft skin, rosy, 
warm and with hair) and necrotic tissue (stiff skin, dark, cool and 
without hair) was demarcated in the animals and the percentage of 
necrosis calculated.
Tram flap’s zone IV biopsies were taken in the 5th 
postoperative day. Skin fragments were fixed in 10% buffered-
formalin and embedded in paraffin for serial sectioning. 
Longitudinal 5-µm sections were stained with hematoxilin and 
eosin (HE) and Masson’s trichrome. Morphologic analysis was 
performed in HE stained sections, while capillaries quantification 
was done in Masson’s trichrome stained areas. Morphometry was 
completed with a grade connected to an optic microscope’s ocular 
with a 10x objective (100x final augmentation). Five sites were 
selected, at random, for number of capillaries count. The final 
result was the average of capillary vessels in these sites.
Statistical analysis
Considering the nature of the data involved in this 
study (percentages of necrosis), non parametric tests were used. 
Wilcoxon sum of ranks test (non parametric, independent groups) 
was used to compare C and P groups, as regards flaps’ percentages 
of necrosis. Student’s t test for independent samples was used to 
analyze capillary vessels number. The significance level was fixed 
in 0.05 or 5% (p≤0.05).
Results
Mean flap’s percentage of necrosis in C group (control) 
was 58.7% and in P group (pentoxifylline), 31.1%. Wilcoxon’s test 
for independent groups showed a significant difference (p=0.002) 
(Figure 1). Mean capillary vessels number in zone IV’s skin in C 
group was 33.4 and in P group was 71.9, a significant difference 
(p=0.008) (Figure 2).
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Discussion
The incidence of breast cancer in caucasian women is 
growing. Treatment involves radical mastectomy in a significant 
percentage of patients, leading to the use of a number of 
mammary reconstruction techniques. The transverse rectus 
abdominis myocutaneous flap (TRAM) is frequently used, but 
necrosis in distant from the pedicle areas is of great concern5,14. 
Pharmacological therapy represents an alternative strategy to 
avoid this complication.
The present study used an experimental model of TRAM 
flap, in the rat. This is a practical, inexpensive and effective method 
to study drugs’ effects and their influences on flap’s perfusion and 
viability5. 
Despite great differences, humans and rats share 
similarities in the vascular anatomy of the rectus abdominis 
muscle. Notwithstanding, the human’s superior vascular pedicle is 
equivalent to the rat’s caudal pedicle5,15,16. 
Clugston et al.6 designed a study with the flap raised in the 
cranial pedicle (dominant pedicle in rats), showing, as expected, 
greater flap viability with pentoxifylline.
In the herein presented work, the caudal pedicle was 
elected, thus allowing better comparison with the daily clinical 
practice in humans (with superior pedicle), as previously 
remembered by Hallock et at.5.
Previous studies showed pentoxifylline’s favorable 
effects in a number of surgical procedures2,6,7,8,11,12,17. 
Pentoxifylline, a haemorreologic agent, presents properties that 
protect tissues from ischemic damages. This drug increases 
erythrocytes’ deformability by raising ATP and cyclic-AMP 
levels. These elements participate in proteins phosphorilation 
inside erythrocyte’s membrane, reduction in plasmatic 
concentration of fibrinogen and reduction in endothelial 
adherence of granulocytes, reducing blood viscosity9,10,18. In 
spite of this haemorreologic effects and thanks to its’ capacity to 
inhibit platelet aggregation (due to increase in the availability of 
ATP, pentoxifylline does not alter normal blood coagulation)17.
Shimizu et al.13 showed that intraperitoneal 
administration of pentoxifylline, for 7 days in the preoperative 
period and in both preoperative (7 days) and postoperative 
(7 days) periods, were both efficient in improving viability 
in ischemic tissues. An explanation for the efficiency of the 
preoperative administration could be the 40 days erythrocytes 
half-life in young rats19. Pentoxifylline does not have acute 
effects in erythrocytes’ membranes, thus it is not effective when 
administered in the postoperative period alone13,20.
The present work showed that pentoxifylline reduced 
necrosis in the caudal  unipedicle TRAM flap in the rat, in 
accordance to previous works that utilized similar methods6,13,18,20, 
an evidence of the positive effect of this drug in reducing 
deleterious consequences of ischemia (Wilcoxon test, p=0.003). 
However, the exact changes that pentoxifylline promoted have not 
been herein assessed. It was demonstrated that this drug led to an 
increase in the number of capillaries in an ischemic zone (zone 
IV), which could be a positive factor to explain the boost in the 
flap’s viability area in pentoxifylline treated animals.
The present work did not elucidate the precise mechanisms 
by which pentoxifylline determined changes at the flap’s 
microcirculation system, but it demonstrated that modification of an 
intrinsic factor (increase in blood circulation) led to improvement 
FIGURE 1 - Mean percentages of TRAM flap’s necrosis in control and 
pentoxifylline groups.
FIGURE 2 - Mean capillary vessels number in zone IV’s skin, per site.
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in TRAM flap’s viability. Recognition that the increase in this 
viability area is mainly due to an increase in capillaries, illustrates 
the powerful effect of blood flow in ischemic areas of this flap.
Conclusions
Pentoxifylline had a beneficial effect in TRAM flap’s 
survival, in the rat. The results herein presented support the 
clinical use of pentoxifylline in mammary reconstruction with the 
TRAM flap.
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